Unity Biotechnology, Inc.·4

Jun 28, 5:22 PM ET

David Nathaniel E 4

4 · Unity Biotechnology, Inc. · Filed Jun 28, 2021

Insider Transaction Report

Form 4
Period: 2021-06-24
David Nathaniel E
DirectorPresident
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-24+11,91811,918 total
    Exercise: $4.18Exp: 2031-06-23Common Stock (11,918 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 24, 2021 or (ii) the date of the 2022 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION